Clinical Trial Update: The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fondaparinux sodium (GSK576428) for acute deep vein thrombosis in Japanese patients has completed, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Venous Thromboembolism

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Thrombosis, Venous | Phase 3 | Status: COMPLETED | Results posted: 2010-06-10